ERBB2 and breast cancer: In our previous experience we analyzed volumetric parameters at baseline [18F]FDG PET/CT and reported that higher values of MTV and TLG of the primary tumor were correlated with residual disease after NAC in Luminal B + HER-2 BC patients [14].